Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tap

Showing results (41-50 of 235) with videos related to

Pageof 24
Sort By:
Oncogenesis|June 20, 2018
Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomasKevin K Chang, Changhwan Yoon, Brendan C Yi, et al.
Molecular Cancer Therapeutics|December 19, 2014
MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcomaEmily K Slotkin, Parag P Patwardhan, Shyamprasad D Vasudeva, et al.
Cancer|June 22, 2010
Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogramTimothy R Donahue, Michael W Kattan, Scott D Nelson, et al.
The Journal of Pathology|June 23, 2023
Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologiesJosephine K Dermawan, Ping Chi, William D Tap, et al.
The American Journal of Surgical Pathology|November 17, 2022
TRAF7-mutated Fibromyxoid Spindle Cell Tumors Are Associated With an Aggressive Clinical Course and Harbor an Undifferentiated Sarcoma Methylation Signature: A Molecular and Clinicopathologic Study of 3 CasesJosephine K Dermawan, Liliana Villafania, Tejus Bale, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 7, 2022
Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic studyJosephine K Dermawan, Sinchun Hwang, Leonard Wexler, et al.
Journal of Cancer Survivorship : Research and Practice|March 11, 2026
Integrative medicine for pain among adolescent and young adult patients with cancer: a scoping reviewHan-Wei V Wu, Chun Sing Lam, Susan Chimonas, et al.
The Oncologist|November 8, 2025
Association of early dexrazoxane with reduced cardiotoxicity risk in sarcoma patients treated with anthracycline chemotherapyKristine H Jang, Joseph S Wallins, I-Hsin Lin, et al.
Molecular Cancer Research : MCR|August 6, 2014
Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumorsJennifer L Anderson, Björn Titz, Ryan Akiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2014
Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTsParag P Patwardhan, Oliver Surriga, Michael J Beckman, et al.
Pageof 24

Showing results (41-50 of 235) with videos related to

Sort By:
Pageof 24
Oncogenesis|June 20, 2018
Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomasKevin K Chang, Changhwan Yoon, Brendan C Yi, et al.
Molecular Cancer Therapeutics|December 19, 2014
MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcomaEmily K Slotkin, Parag P Patwardhan, Shyamprasad D Vasudeva, et al.
Cancer|June 22, 2010
Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogramTimothy R Donahue, Michael W Kattan, Scott D Nelson, et al.
The Journal of Pathology|June 23, 2023
Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologiesJosephine K Dermawan, Ping Chi, William D Tap, et al.
The American Journal of Surgical Pathology|November 17, 2022
TRAF7-mutated Fibromyxoid Spindle Cell Tumors Are Associated With an Aggressive Clinical Course and Harbor an Undifferentiated Sarcoma Methylation Signature: A Molecular and Clinicopathologic Study of 3 CasesJosephine K Dermawan, Liliana Villafania, Tejus Bale, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 7, 2022
Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic studyJosephine K Dermawan, Sinchun Hwang, Leonard Wexler, et al.
Journal of Cancer Survivorship : Research and Practice|March 11, 2026
Integrative medicine for pain among adolescent and young adult patients with cancer: a scoping reviewHan-Wei V Wu, Chun Sing Lam, Susan Chimonas, et al.
The Oncologist|November 8, 2025
Association of early dexrazoxane with reduced cardiotoxicity risk in sarcoma patients treated with anthracycline chemotherapyKristine H Jang, Joseph S Wallins, I-Hsin Lin, et al.
Molecular Cancer Research : MCR|August 6, 2014
Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumorsJennifer L Anderson, Björn Titz, Ryan Akiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2014
Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTsParag P Patwardhan, Oliver Surriga, Michael J Beckman, et al.
Pageof 24